Jasper Therapeutics, Inc. (JSPR) Operating cash flow 2020–2025
Jasper Therapeutics, Inc. (JSPR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$77.2MFY2025 · since FY2020: -$18.3M → -$77.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$77.2M | -23.3% |
| FY2024 | -$62.6M | -20.2% |
| FY2023 | -$52.1M | -13.5% |
| FY2022 | -$45.9M | -36.2% |
| FY2021 | -$33.7M | -84.4% |
| FY2020 | -$18.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JSPR financial trends
JSPR RevenueJSPR Net incomeJSPR Net marginJSPR Gross profitJSPR Gross marginJSPR Operating incomeJSPR Operating marginJSPR Free cash flowJSPR Capital expendituresJSPR Return on equityJSPR Stock buybacksJSPR Dividends paidJSPR Total assetsJSPR Total liabilitiesJSPR Shareholders’ equityJSPR overview →